Subsidiary of Beijing Strong Biotechnologies, Inc. (300406.SZ) obtains multiple medical device registration certificates.
Jiuqiang Biological (300406.SZ) announced that its wholly-owned subsidiary, Fuzhou Maixin Biotechnology Development Co., Ltd., recently received the "Medical Device Registration Certificate" issued by the National Medical Products Administration. The product names are: HER2 Antibody Reagent (Immunohistochemistry), Progesterone Receptor Antibody Reagent (Immunohistochemistry), and CD20 Antibody Reagent (Immunohistochemistry).
Announcement from Beijing Strong Biotechnologies, Inc. (300406.SZ): The company's wholly-owned subsidiary, Fuzhou Mainew Biotechnology Development Co., Ltd., recently received the "Medical Device Registration Certificate" issued by the National Medical Products Administration. The products include: HER2 antibody reagent (immunohistochemistry method), progesterone receptor antibody reagent (immunohistochemistry method), CD20 antibody reagent (immunohistochemistry method).
Related Articles
FUTURE MACH LTD (01401): Zheng Qichang has resigned as an independent non-executive director.
HANISON (00896): Ma Liqiong resigns as Company Secretary and Authorized Representative
As of the end of March, China Railway (00390) had repurchased a total of 28.812 million A-shares.
FUTURE MACH LTD (01401): Zheng Qichang has resigned as an independent non-executive director.
HANISON (00896): Ma Liqiong resigns as Company Secretary and Authorized Representative
As of the end of March, China Railway (00390) had repurchased a total of 28.812 million A-shares.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
